Tamar Ben Yedidia

Company: Scinai Immunotherapeutics

Job title: CSO and clinical management

Seminars:

Elevating Dermatological Drug Development Through Advanced Inflammatory Marker Targeting Methodology 11:00 am

• Speaking to preclinical study design to evaluate anti-interleukin 17 NanoAbs as a treatment for plaque psoriasis, which showed the downregulation of psoriasis molecular markers • Leveraging 3D biologic skin models to mimic the structure of human skin to suggest NanoAbs’ therapeutic potential • Demonstrating the potential for a systemic novel approach with higher affinity…Read more

day: Day One